Cite
MLA Citation
Xinyan Yang et al.. “Patient‐reported outcomes of a phase II neoadjuvant apalutamide (ARN‐509) and radical prostatectomy in treatment of intermediate‐ to high‐risk prostate cancer (NEAR) trial.” International journal of urology, vol. 29, 2022, pp. 1322–1330. http://access.bl.uk/ark:/81055/vdc_100169536584.0x000044